ObsEva SA: ObsEva Appoints Fabien de Ladonchamps as Chief Executive Officer
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland - May 2, 2023 - ObsEva SA (SIX: OBSN), a biopharmaceutical company developing novel therapies for women's
Source: finanznachrichten.de